Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial

Peuker, Caroline A.; Yaghobramzi, Sarvenaz; Grunert, Corinna; Keilholz, Luisa; Gjerga, Enio; Hennig, Steffen; Schaper, Sigrid; Na, Il-Kang; Keller, Ulrich; Brucker, Sara; Decker, Thomas; Fasching, Peter; Fehm, Tanja; Janni, Wolfgang; Kuemmel, Sherko; Schneeweiss, Andreas; Schuler, Martin; Lueftner, Diana; Busse, Antonia

Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial

Autor(en):

Peuker, Caroline A.; Yaghobramzi, Sarvenaz; Grunert, Corinna; Keilholz, Luisa; Gjerga, Enio; Hennig, Steffen; Schaper, Sigrid; Na, Il-Kang; Keller, Ulrich; Brucker, Sara; Decker, Thomas; Fasching, Peter; Fehm, Tanja; Janni, Wolfgang; Kuemmel, Sherko; Schneeweiss, Andreas; Schuler, Martin; Lueftner, Diana; Busse, Antonia

Tübinger Autor(en):

Brucker, Sara

Erschienen in:

European Journal of Cancer (2022), Bd. 162, S. 45-55

Verlagsangabe:

Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ejca.2021.11.025

ISSN:

0959-8049